GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Volatility

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Volatility : 24.63% (As of May. 30, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2024-05-30), Sun Pharmaceuticals Industries's Volatility is 24.63%.


Competitive Comparison of Sun Pharmaceuticals Industries's Volatility

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharmaceuticals Industries's Volatility Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Volatility distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Volatility falls into.



Sun Pharmaceuticals Industries  (NSE:SUNPHARMA) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sun Pharmaceuticals Industries  (NSE:SUNPHARMA) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Sun Pharmaceuticals Industries Volatility Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines